(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202103 | 202003 | % Var | 202103 | 202003 | % Var | 202103 | 202003 | % Var | |
| Sales | 4520.80 | 4065.70 | 11.19 | 19148.90 | 16349.20 | 17.12 | 19148.90 | 16349.20 | 17.12 |
| Other Income | 8.50 | 6.20 | 37.10 | 64.20 | 10.60 | 505.66 | 64.20 | 10.60 | 505.66 |
| PBIDT | 792.40 | 682.20 | 16.15 | 4076.90 | 2454.60 | 66.09 | 4076.90 | 2454.60 | 66.09 |
| Interest | 43.40 | 72.40 | -40.06 | 226.10 | 322.00 | -29.78 | 226.10 | 322.00 | -29.78 |
| PBDT | 749.00 | 693.60 | 7.99 | 3853.00 | 2216.40 | 73.84 | 3853.00 | 2216.40 | 73.84 |
| Depreciation | 116.60 | 119.90 | -2.75 | 476.00 | 466.70 | 1.99 | 476.00 | 466.70 | 1.99 |
| PBT | 632.40 | 573.70 | 10.23 | 3377.00 | 1749.70 | 93.00 | 3377.00 | 1749.70 | 93.00 |
| TAX | 130.00 | 8.10 | 1504.94 | 800.00 | 393.00 | 103.56 | 800.00 | 393.00 | 103.56 |
| Deferred Tax | -20.00 | -155.00 | -87.10 | -45.00 | -102.50 | -56.10 | -45.00 | -102.50 | -56.10 |
| PAT | 502.40 | 565.60 | -11.17 | 2577.00 | 1356.70 | 89.95 | 2577.00 | 1356.70 | 89.95 |
| Equity | 932.00 | 233.00 | 300.00 | 932.00 | 233.00 | 300.00 | 932.00 | 233.00 | 300.00 |
| PBIDTM(%) | 17.53 | 16.78 | 4.46 | 21.29 | 15.01 | 41.81 | 21.29 | 15.01 | 41.81 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: